4521 — Kaken Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Kaken Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	—	—	—	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	77,305	74,624	74,260	65,324	70,085
Net Total Accounts Receivable
Net Total Receivables	20,549	20,260	19,268	23,744	21,178
Total Inventory
Total Other Current Assets
Total Current Assets	113,662	110,613	109,903	106,974	111,377
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,020	25,734	25,498	25,355	27,629
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	163,332	165,181	166,328	171,623	190,422
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21,276	19,049	20,838	19,024	30,354
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	27,075	27,434	30,070	27,868	37,788
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	136,257	137,747	136,258	143,755	152,634
Total Liabilities & Shareholders' Equity	163,332	165,181	166,328	171,623	190,422
Total Common Shares Outstanding